Make An Impact In The Fight Against Breast Cancer

Susan G. Komen Florida Legislative Priorities

Stage Four Advanced, Metastatic Cancer Step Therapy HB 261/SB 672

Step therapy also referred to as “fail first”, requires a patient to first try a preferred (often generic alternative) drug prior to receiving coverage for the originally prescribed drug.  Step therapy is a method of utilization management health plans employ to control costs by beginning treatment with more cost-effective drug therapy and then progressing to the newer, more costly treatments only if necessary. Legislation can prohibit health plan companies from requiring enrollees to follow step therapy protocols for stage four advanced metastatic cancer. This legislation does not prohibit the use of generics for treatments and only serves to ensure that the patient has access to most appropriate treatment for their condition. Click here to read more.

Diagnostic Imaging Coverage HB 263/SB 416

Traditional screening mammography is an x-ray examination of the breast of an asymptomatic woman.  Once signs or symptoms of breast disease have been found, diagnostic imaging (diagnostic mammography, ultrasound, breast MRI, etc) is recommended. In addition, diagnostic imaging may be recommended for women who have a prior history of breast cancer. Click here to read more.

The Mary Brogan Program

The Florida Breast and Cervical Early Detection Program, better known as the Mary Brogan Program, is a federal-state partnership between the Center for Disease Control and Prevention (CDC) and the Florida Department of Health, providing potentially life-saving breast cancer screening and diagnostic services to low-income, uninsured and underinsured women who do not qualify for Medicaid. Click here to read more.

 

Susan G. Komen Advocacy Priorities

Every two years, Komen identifies the advocacy issues where Komen’s voice could provide the greatest potential impact on achieving our Bold Goal. A broad-based, intensive vetting and selection process includes feedback from Affiliates, representatives from the African-American Health Equity Initiative (AAHEI), metastatic breast cancer community, Advocates in Science (AIS), Komen Scholars and subject matter experts. The following issues form the basis for Komen’s state and federal public policy and advocacy work through 2020.

2019 – 2020 Public Policy & Advocacy Priorities

 

Komen Florida Advocacy in the News

Access to Breast Cancer Diagnosis Act (H.R.2428) – August 15, 2019

Susan G. Komen Florida Advocacy Advisory Taskforce’s Support of Mary Brogan Program Helps Preserve Breast Cancer Funding in FY20 State Budget – May 8, 2019

New Susan G. Komen Florida Advocacy Advisory Taskforce Takes Aim at Reducing State’s Yearly 2,700 Breast Cancer Deaths – May 6, 2019

Say thank you to Legislators for joining Susan G. Komen in the fight against breast cancer!

Click here for a sample language to include in your thank you and click here for a list of the co-sponsors and their contact emails.

Become an Advocate

Komen Advocacy Alliance

The Susan G. Komen Advocacy Alliance (KAA) is the non-partisan voice for over 2.5 million breast cancer survivors and the people who love them. Our mission is to translate the Komen promise to end breast cancer forever into action at all levels of government to discover and deliver the cures.

Go to Top